GPOH Konsortium Sichelzellkrankheit
Industry / private company
Location:
Köln,
Germany (DE)
ISNI: -
Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea (2022)
Allard P, Alhaj N, Lobitz S, Cario H, Jarisch A, Grosse R, Oevermann L, et al.
Journal article
Sickle cell disease in Germany: Results from a national registry (2019)
Kunz JB, Lobitz S, Grosse R, Oevermann L, Hakimeh D, Jarisch A, Cario H, et al.
Journal article